SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015596
Filing Date
2022-08-08
Accepted
2022-08-08 17:01:45
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ccxi-20220630.htm   iXBRL 10-Q 2740176
2 EX-31.1 ccxi-ex31_1.htm EX-31.1 15105
3 EX-31.2 ccxi-ex31_2.htm EX-31.2 14951
4 EX-32.1 ccxi-ex32_1.htm EX-32.1 10885
5 EX-32.2 ccxi-ex32_2.htm EX-32.2 10910
  Complete submission text file 0000950170-22-015596.txt   9723308

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ccxi-20220630.xsd EX-101.SCH 57795
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ccxi-20220630_pre.xml EX-101.PRE 327567
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ccxi-20220630_cal.xml EX-101.CAL 56782
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ccxi-20220630_lab.xml EX-101.LAB 460171
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ccxi-20220630_def.xml EX-101.DEF 165719
65 EXTRACTED XBRL INSTANCE DOCUMENT ccxi-20220630_htm.xml XML 2013629
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 221145248
SIC: 2834 Pharmaceutical Preparations